Paola Tatarelli

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

Lucia Taramasso, Paola Tatarelli, Elena Ricci et al. · BMC Infectious Diseases · 2018 · 63 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity

Elio Castagnola, Paola Tatarelli, Alessio Mesini et al. · Journal of Infection and Public Health · 2018 · 38 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis

Lucia Taramasso, Laura Magnasco, Bianca Bruzzone et al. · Journal of Clinical Virology · 2019 · 35 citations

Life Sciences, Infectious Diseases, Microbiology +12

Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil

Daniele Roberto Giacobbe, Patrícia Esteves, Paolo Bruzzi et al. · Clinical Microbiology and Infection · 2015 · 31 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, Ethiopia

Raffaella Bucciardini, Vincenzo Fragola, Teshome Abegaz et al. · BMJ Global Health · 2017 · 20 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +15